Skip to main content
Clinical Trials/CTRI/2017/11/010661
CTRI/2017/11/010661Completed未知

A study of efficacy of Fractional CO2 Laser along with topical 1% Terbinafine in treatment of onychomycosis - FRACO

Command Hospital Air Force0 sites26 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
26

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Males and females over the age of 18 years
  • 2.Patient with one or more toenail and/or fingernail fungal infections of the following types: distal subungual onychomycosis, proximal subungual onychomycosis, superficial white or black onychomycosis, mixed patterns or total dystrophic type onychomycosis.
  • 3.Confirm diagnosis using fungal culture and direct microscopy

Exclusion Criteria

  • 1.Fungal culture negative or no evidence on direct microscopy.
  • 2.Those patients who used systemic or topical antifungal in the past three months of the first scheduled laser session to be excluded.
  • 3.Conditions, like bacterial infections, subungual hematoma, associated nail disorders which produce changes in the nail plate like psoriasis, atopic dermatitis, lichen planus.
  • 4.Pregnant women.

Investigators

Sponsor
Command Hospital Air Force

Similar Trials